DOI: 10.1055/s-00034925

Hämostaseologie

Ausgabe 04 · Volume 41 · August 2021 DOI: 10.1055/s-011-51625

Erratum

e1
Tiede, A.: Erratum: Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII?

Editorial

237
Knöbl, Paul; Scharf, Rüdiger E.: Theme Issue: “Critical Management Decisions in Hemostasis and Thrombosis”

Review Article

240
Tiede, Andreas: Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII?
247
Chowdary, Pratima: Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia
257
Riva, Nicoletta; Calleja-Agius, Jean: Ovarian Vein Thrombosis: A Narrative Review
267
Nopp, Stephan; Ay, Cihan: Bleeding Risk Assessment in Patients with Venous Thromboembolism
275
Althaus, Karina; Faul, Christoph; Bakchoul, Tamam: New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia
283
Bécel, Gaëlle; Faict, Sylvia; Picod, Adrien; Bouzid, Raïda; Veyradier, Agnès; Coppo, Paul: Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical Research
294
Buchtele, Nina; Staudinger, Thomas; Schäfer, Anne-Kristin; Bögl, Magdalena Sophie; Schoergenhofer, Christian; Schwameis, Michael: Anticoagulation in Critically Ill Adults during Extracorporeal Circulation
307
Gratz, Johannes; Oberladstätter, Daniel; Schöchl, Herbert: Trauma-Induced Coagulopathy and Massive Bleeding: Current Hemostatic Concepts and Treatment Strategies

GTH News

317
GTH News

Mitteilungen des Vorstandes des Berufsverbandes der Deutschen Hämostaseologen e.V. (BDDH)

323
Koscielny, Jürgen; Sucker, Christoph: Im letzten Augenblick verhindert: Geplante Übertragung der Richtlinienbefugnis bezüglich Herstellung und Anwendung von Blut und Blutprodukten von der Bundesärztekammer (BÄK) auf das Paul-Ehrlich-Institut (PEI) und das Robert-Koch-Institut (RKI)